Cutaneous T-cell lymphoma following dupilumab use – A real-world pharmacovigilance study of the FDA adverse event reporting system (FAERS).

HOME
>
論文・技術情報
>
Cutaneous T-cell lymphoma following dupilumab use – A real-world pharmacovigilance study of the FDA adverse event reporting system (FAERS).

アブストラクト
ジャーナル名	The Journal of investigative dermatology
投稿日	2024/7/1
投稿者	Lavin, Leore; Dusza, Stephen; Geller, Shamir
組織名	Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer;Center, New York, NY 10021.;Center, New York, NY 10021. Electronic address: gellers@mskcc.org.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/38945437/

タグ:

お問合わせ

キーワード